AstraZeneca’s CEO Pascal Soriot has dismissed continued rumours about his departure as “fake news” as the company announced full year results showing sales growth for the first time in a decade.
But the British drugmaker did not compensate its CEO accordingly, as Pascal Soriot’s pay package dipped 16% from 17.4 million pounds sterling ($21.9 million) in 2023 to 14.7 million pounds ($18. ...
Pascal Soriot, 65, topped up his basic salary of £1.8million with extras that included a bonus of £3.5million and share awards totalling £9.4million in 2024. The award took Frenchman’s total ...
The pharmaceutical giant behind a variety of medicines paid its chief executive Pascal Soriot £14.7m in 2024. This was made up of a salary worth £1.5m an annual bonus and long-term incentive awards.
Pascal Soriot is the CEO of Astrazeneca. Astrazeneca is too big and complex to base its chief executive’s pay packet on the rest of the FTSE index, according to the chair of its remuneration ...
Rolls-Royce CEO Tufan Erginbilgic has seen a dramatic pay cut of nearly £10m, despite delivering impressive results for the ...
Addressing key challenges in healthcare, Pascal Soriot, CEO of AstraZeneca, encouraged governments to develop policies that enable early disease diagnostics, improve accessibility, and encourage ...
The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million in 2024. The chief executive of drugmaker AstraZeneca was handed a pa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results